Kidney Health Package at Home

Professional Home Kidney Testing — Complete Renal Function & Disease Screening

Concerned about your kidney health? Family history of kidney disease? Diabetes or high blood pressure? Our comprehensive Kidney Health Package at home provides complete renal function assessment through advanced blood and urine testing, measuring filtration capacity, electrolyte balance, protein leakage, and early markers of kidney damage—all delivered directly to your doorstep across Dubai, Sharjah, Ajman, and all UAE emirates.

Your kidneys are your body's filtration system—two fist-sized organs that filter 200 liters of blood daily, removing waste products, balancing electrolytes, regulating blood pressure, producing red blood cell hormone (erythropoietin), and activating vitamin D for bone health. Chronic kidney disease (CKD) affects 1 in 7 adults globally, and in the UAE, diabetes and hypertension drive epidemic rates. The tragedy: kidney disease is silent—90% of kidney function can be lost before symptoms appear. Early detection through screening can prevent kidney failure, dialysis, and transplantation. Our DHA-licensed medical team brings hospital-quality nephrology testing to your home, processing samples in accredited laboratories, delivering detailed results within 24-48 hours, and connecting you with nephrologists or physicians for expert diagnosis and kidney-protective treatment.

Available 7 Days/Week | Fasting Blood & Urine Collection | Insurance Accepted | CKD Monitoring Programs

Understanding Chronic Kidney Disease: The Silent Epidemic in UAE

Chronic Kidney Disease (CKD) is progressive, irreversible kidney damage causing declining filtration function (measured by eGFR—estimated glomerular filtration rate) and/or evidence of kidney structural abnormality (proteinuria, imaging abnormalities) persisting for more than 3 months. Unlike acute kidney injury (sudden, often reversible), CKD develops gradually over years to decades, often without symptoms until advanced stages.

Alarming UAE Kidney Disease Statistics

Prevalence & Impact

• 15-20% of UAE adults have CKD (Stage 1-5) based on screening studies
• Diabetes is the leading cause (40-45% of CKD cases)—19% of the UAE population is diabetic
• Hypertension is the second leading cause (25-30% of CKD)—affects 25% of adults
• End-Stage Renal Disease (ESRD) increasing 8-10% annually
• 1,500+ patients on dialysis in UAE (requiring 3x weekly, 4-hour sessions)
• Average wait for kidney transplant: 3-5 years
• Cost burden: Dialysis costs AED 100,000-150,000 annually per patient

Consequences of Untreated CKD

• Progression to kidney failure requiring dialysis or transplantation
• Cardiovascular disease (CKD doubles to quadruples heart attack/stroke risk)
• Anemia (fatigue, weakness from decreased erythropoietin)
• Bone disease (mineral imbalances, fractures)
• Electrolyte imbalances (dangerous heart rhythms, muscle weakness)
• Fluid overload (swelling, shortness of breath, heart failure)
• Significantly reduced life expectancy

The Critical Problem: CKD is asymptomatic until Stage 4-5 (advanced disease). Routine screening is the ONLY way to detect early kidney damage when interventions can slow or halt progression.

How Kidney Disease Progresses (CKD Stages)

Stage 1: Kidney Damage with Normal Function

• eGFR: ≥90 mL/min/1.73m² (normal or high)
• Evidence of damage: Persistent proteinuria (protein in urine), imaging abnormalities, biopsy-proven disease
• Symptoms: None
• Prevalence: 3-5% of adults
• Action: Treat underlying cause (diabetes, hypertension control), slow progression
• Prognosis: Progression preventable with treatment

Stage 2: Mild Reduction in Kidney Function

• eGFR: 60-89 mL/min/1.73m²
• Evidence of damage: Proteinuria or structural abnormality
• Symptoms: Usually none
• Prevalence: 5-8% of adults
• Action: Aggressive risk factor management, medication to protect kidneys (ACE inhibitors, ARBs)
• Prognosis: Progression can be slowed significantly

Stage 3a: Mild to Moderate Reduction

• eGFR: 45-59 mL/min/1.73m²
• Kidney function: 45-59% of normal
• Symptoms: May develop subtle symptoms (mild fatigue, slight fluid retention)
• Prevalence: 5-7% of adults
• Complications: Beginning metabolic disturbances (phosphorus retention, vitamin D deficiency)
• Action: Nephrology referral, kidney-protective medications, dietary modifications
• Prognosis: With treatment, can remain stable for years

Stage 3b: Moderate to Severe Reduction

• eGFR: 30-44 mL/min/1.73m²
• Kidney function: 30-44% of normal
• Symptoms: Fatigue, fluid retention (swelling in legs), mild anemia possible
• Complications: Anemia, bone disease, electrolyte imbalances beginning
• Action: Regular nephrology care, anemia treatment (erythropoietin, iron), phosphorus binders, vitamin D supplementation
• Prognosis: Higher risk of progression; dialysis preparation may begin

Stage 4: Severe Reduction (Pre-Dialysis)

• eGFR: 15-29 mL/min/1.73m²
• Kidney function: 15-29% of normal
• Symptoms: Noticeable—fatigue, nausea, loss of appetite, fluid retention, shortness of breath, itching, metallic taste
• Complications: Anemia, bone disease, metabolic acidosis, hyperkalemia (high potassium—dangerous), uremia symptoms
• Action: Nephrology specialty care, dialysis access placement (fistula creation), transplant evaluation, comprehensive metabolic management
• Prognosis: Likely progression to Stage 5 within 1-3 years; prepare for renal replacement therapy

Stage 5: Kidney Failure (End-Stage Renal Disease – ESRD)

• eGFR: <15 mL/min/1.73m²
• Kidney function: <15% of normal
• Symptoms: Severe—uremia (toxin buildup causing confusion, nausea, vomiting), fluid overload (pulmonary edema), dangerous electrolyte imbalances, malnutrition
• Action required: DIALYSIS (hemodialysis 3x weekly or peritoneal dialysis daily) or KIDNEY TRANSPLANTATION
• Without treatment: Life-threatening within weeks to months
• Prognosis: Lifelong dialysis or successful transplant (10-year graft survival ~60-80%)

Our screening detects Stages 1-3, when aggressive treatment can prevent progression to dialysis.

Who Needs the Kidney Health Package? Critical Risk Factors

Mandatory Screening Groups

People with Diabetes (Type 1 or Type 2) – Highest Risk

• 40-50% of dialysis patients are diabetic
• Diabetic nephropathy (kidney damage from high blood sugar) is the leading cause of kidney failure worldwide
• Mechanism: High glucose damages kidney filtering units (glomeruli), causes scarring
• Risk increases with: duration of diabetes (>10 years especially high risk), poor glucose control (HbA1c >7%), coexisting hypertension
• Action: Annual kidney screening MANDATORY for all diabetics; every 6 months if abnormal results
• Critical tests: eGFR, urine albumin-to-creatinine ratio (ACR)

People with High Blood Pressure (Hypertension)

• Second leading cause of CKD (25-30% of cases)
• Bidirectional relationship: Hypertension damages kidneys; kidney disease worsens hypertension
• Mechanism: High pressure damages kidney blood vessels, reduces filtration, causes scarring
• Risk factors: uncontrolled hypertension (BP >140/90), longstanding hypertension (>10 years), resistant hypertension (requires 3+ medications)
• Action: Annual kidney screening; more frequent if BP uncontrolled
• Target BP with CKD: <130/80 mmHg (stricter than general population)

Family History of Kidney Disease

• Genetic kidney diseases: polycystic kidney disease (PKD—autosomal dominant; 50% chance if parent affected), Alport syndrome (genetic collagen defect causing progressive kidney failure and hearing loss), IgA nephropathy (familial clustering), focal segmental glomerulosclerosis (FSGS)
• Familial clustering of diabetic and hypertensive kidney disease (genetic predisposition)
• Action: Baseline screening age 18-20 if family history; annually thereafter
• Genetic testing available for PKD and other hereditary conditions

People Over Age 60

• eGFR naturally declines with aging (1 mL/min per year after age 40)
• 15-20% of elderly have CKD Stage 3+
• Increased vulnerability to kidney injury from medications, dehydration, infections
• Action: Screening recommended for all adults 60+ every 1-2 years minimum

Cardiovascular Disease (Heart Disease, Stroke, Peripheral Artery Disease)

• CKD and CVD strongly linked (shared risk factors, bidirectional causation)
• Heart disease accelerates kidney damage; kidney disease accelerates heart disease
• 20-40% of heart attack patients have CKD
• Action: Annual kidney screening for all cardiovascular patients

Obesity (BMI ≥30 kg/m²)

• Obesity-related glomerulopathy (direct kidney damage from excess weight)
• Mechanism: Increased kidney workload, inflammation, activation of RAAS (kidney blood pressure system)
• Associated with diabetes, hypertension, metabolic syndrome
• Action: Baseline screening, annual monitoring, aggressive weight loss intervention

Smoking (Current or Former)

• Accelerates kidney disease progression 2-3x
• Damages kidney blood vessels, increases proteinuria
• Particularly harmful in diabetics or hypertensives
• Action: Annual screening; smoking cessation counseling mandatory

Chronic NSAID Use (Ibuprofen, Naproxen, Diclofenac)

• Common cause of chronic kidney disease (analgesic nephropathy)
• Mechanism: Reduces kidney blood flow, causes interstitial nephritis
• High risk: Daily use >3 months, high doses
• Alternatives: Acetaminophen (safer), physical therapy, targeted treatments
• Action: Kidney screening before starting chronic NSAIDs; every 6-12 months during use

Recurrent Urinary Tract Infections (UTIs) or Kidney Stones

• Chronic/recurrent UTIs can cause scarring (chronic pyelonephritis)
• Kidney stones may cause obstruction, infection, direct damage
• Vesicoureteral reflux (urine backflow—common in children)
• Action: Screening for underlying kidney damage; imaging to detect structural abnormalities

Autoimmune Diseases

• Lupus (SLE): 50% develop lupus nephritis (kidney inflammation)
• Rheumatoid arthritis, vasculitis, scleroderma: Kidney involvement possible
• Mechanism: Immune complexes deposit in kidneys, cause inflammation
• Action: Regular kidney monitoring (every 3-6 months); requires aggressive immunosuppression if kidney involvement

Previous Acute Kidney Injury (AKI)

• History of sudden kidney failure from dehydration, infection, medications, surgery
• 25-50% increased risk of developing CKD after an AKI episode
• Mechanism: Incomplete recovery, scarring
• Action: Kidney function monitoring 3, 6, 12 months post-AKI, then annually

Chronic Infections (HIV, Hepatitis B, Hepatitis C)

• HIV-associated nephropathy (HIVAN)
• Hepatitis B/C: Glomerulonephritis, cryoglobulinemia
• Medications for infections can be nephrotoxic
• Action: Baseline and regular kidney monitoring

Cancer Patients (Chemotherapy, Radiation)

• Nephrotoxic chemotherapy: Cisplatin, ifosfamide, methotrexate
• Tumor lysis syndrome (rapid cancer cell death releasing toxins)
• Radiation damage if kidneys in treatment field
• Action: Baseline kidney function; monitoring during and after treatment

Organ Transplant Recipients

• Immunosuppressive medications (tacrolimus, cyclosporine) are nephrotoxic
• Increased infection risk
• Action: Frequent kidney monitoring (monthly initially, then every 3-6 months)

Symptoms Suggesting Kidney Disease

Early symptoms (often subtle or absent)

• Fatigue and low energy
• Difficulty concentrating
• Poor appetite
• Sleep disturbances
• Muscle cramping (especially at night)
• Swollen feet and ankles (edema)
• Puffiness around eyes (especially morning)
• Increased urination frequency (especially nighttime)
• Foamy or bubbly urine (proteinuria)

Advanced symptoms (Stage 4-5)

• Severe fatigue, weakness
• Nausea and vomiting
• Loss of appetite, weight loss
• Metallic taste, bad breath (uremia)
• Shortness of breath (fluid overload, anemia)
• Severe swelling (legs, hands, face)
• Confusion, difficulty thinking (uremic encephalopathy)
• Itching (uremic pruritus)
• Restless legs syndrome
• Decreased urine output (oliguria)
• Blood in urine (hematuria)
• High blood pressure (difficult to control)

Action: Any symptoms require immediate comprehensive kidney evaluation.

Comprehensive Kidney Health Package: Complete Renal Function Panel

Our evidence-based kidney screening includes all essential blood and urine tests for disease detection, staging, and monitoring:

Core Kidney Function Tests (Blood)

Serum Creatinine – Foundation of Kidney Function Assessment

What it measures: Waste product from muscle metabolism; normally filtered and excreted by kidneys.

Normal range:

• Men: 0.7-1.3 mg/dL (62-115 μmol/L)
• Women: 0.6-1.1 mg/dL (53-97 μmol/L)

Interpretation:

• Normal: Good kidney filtration
• Elevated (>1.3 mg/dL men, >1.1 women): Reduced kidney function
• Very high (>2.0 mg/dL): Significant kidney impairment
• Extremely high (>10 mg/dL): Severe kidney failure, dialysis likely needed

Important: Creatinine is influenced by muscle mass (bodybuilders have higher baseline; elderly/frail have lower). eGFR is a more accurate assessment.

eGFR (Estimated Glomerular Filtration Rate) – Most Important Kidney Function Test

What it measures: Estimated kidney filtration capacity (how many milliliters of blood the kidneys filter per minute, adjusted for body surface area).

Calculated from: Creatinine, age, sex, race using the CKD-EPI equation (most accurate).

Normal: >90 mL/min/1.73m²

CKD staging by eGFR:

• Stage 1 (kidney damage, normal function): ≥90 mL/min/1.73m²
• Stage 2 (mild reduction): 60-89 mL/min/1.73m²
• Stage 3a (mild-moderate reduction): 45-59 mL/min/1.73m²
• Stage 3b (moderate-severe reduction): 30-44 mL/min/1.73m²
• Stage 4 (severe reduction): 15-29 mL/min/1.73m²
• Stage 5 (kidney failure): <15 mL/min/1.73m²

Clinical significance:

• Single most important number for kidney health
• Guides medication dosing (many drugs require adjustment based on eGFR)
• Determines CKD stage and prognosis
• Indicates need for nephrology referral (eGFR <60)
• Triggers dialysis/transplant evaluation (eGFR <20)

Trend more important than single value: Stable eGFR is better than declining eGFR, even if in the same stage.

Blood Urea Nitrogen (BUN) – Waste Product Marker

What it measures: Nitrogen waste from protein breakdown; filtered by kidneys.

Normal range: 7-20 mg/dL (2.5-7.1 mmol/L)

Interpretation:

• Elevated BUN with elevated creatinine: Kidney dysfunction
• Elevated BUN with normal creatinine: Dehydration, high-protein diet, GI bleeding, catabolic state (not kidney disease)
• Very high (>100 mg/dL): Severe kidney failure, uremia

BUN/Creatinine ratio:

• Normal: 10:1 to 20:1
• Ratio >20:1: Pre-renal (dehydration, heart failure, GI bleeding)
• Ratio <10:1: Liver disease, malnutrition, overhydration

Uric Acid

What it measures: End product of purine metabolism; can crystallize in joints (gout) and kidneys (stones).

Normal range:

• Men: 3.5-7.2 mg/dL (208-428 μmol/L)
• Women: 2.6-6.0 mg/dL (155-357 μmol/L)

Interpretation:

• Elevated: Gout risk, kidney stone risk, may indicate kidney dysfunction
• Very high (>10 mg/dL): High risk of acute uric acid nephropathy (tumor lysis syndrome)

CKD connection: Kidney disease causes uric acid elevation; high uric acid may also contribute to kidney disease progression (controversial).

Electrolyte Panel (Critical for Kidney Disease)

Sodium (Na+)

Function: Major blood electrolyte; regulates fluid balance, blood pressure, nerve/muscle function.

Normal range: 135-145 mEq/L (mmol/L)

Abnormalities in kidney disease:

• Hyponatremia (<135): Dilutional from fluid retention or diuretic use
• Hypernatremia (>145): Dehydration, rare in CKD

Severe imbalances cause: Confusion, seizures, coma.

Potassium (K+) – Critical Monitoring in CKD

Function: Essential for heart rhythm, muscle contraction, nerve function.

Normal range: 3.5-5.0 mEq/L (mmol/L)

Kidney disease risk:

• Hyperkalemia (>5.5 mEq/L): DANGEROUS—can cause fatal cardiac arrhythmias
• Mechanism: Kidneys can't excrete potassium adequately
• Worse with: ACE inhibitors/ARBs (kidney-protective but increase potassium), potassium-sparing diuretics, high-potassium diet

Symptoms of hyperkalemia:

• Muscle weakness
• Palpitations, irregular heartbeat
• Nausea
• Severe: Cardiac arrest (medical emergency)

Management:

• Dietary restriction: Avoid high-potassium foods (bananas, oranges, tomatoes, potatoes, beans)
• Potassium binders: Patiromer, sodium zirconium cyclosilicate
• Emergency treatment: Calcium gluconate (cardiac protection), insulin + glucose, dialysis

Chloride (Cl-)

Function: Maintains acid-base balance, fluid balance.

Normal range: 96-106 mEq/L (mmol/L)

Moves with sodium in most conditions.

Bicarbonate (HCO3-) / CO2

Function: Buffer maintaining blood pH (acid-base balance).

Normal range: 22-29 mEq/L (mmol/L)

Kidney disease complication:

• Metabolic acidosis (low bicarbonate <22): Kidneys can't excrete acid adequately
• Stage 4-5 CKD: Very common
• Consequences: Bone disease, muscle wasting, progression of kidney disease

Treatment: Sodium bicarbonate supplementation (baking soda tablets).

Calcium (Ca2+)

Function: Bone health, muscle contraction, nerve signaling, blood clotting.

Normal range: 8.5-10.5 mg/dL (2.1-2.6 mmol/L)

Kidney disease complications:

• Hypocalcemia (low calcium): Decreased vitamin D activation (kidneys activate vitamin D; CKD impairs this)
• Symptoms: Muscle cramps, tingling, bone pain, osteoporosis
• Treatment: Calcium supplements, activated vitamin D (calcitriol)

Phosphorus (PO4) – Critical in Advanced CKD

Function: Bone health, energy production (ATP), cell membranes.

Normal range: 2.5-4.5 mg/dL (0.8-1.4 mmol/L)

Kidney disease complication:

• Hyperphosphatemia (elevated phosphorus): Kidneys can't excrete phosphorus
• Begins: Stage 3b-4 CKD
• Consequences: combines with calcium → vascular calcification (heart attack, stroke risk), secondary hyperparathyroidism (bone disease), itching (pruritus), soft tissue calcification

Management:

• Dietary restriction: Limit dairy, nuts, beans, processed foods (phosphate additives)
• Phosphate binders: Calcium carbonate, sevelamer (taken with meals to bind dietary phosphorus)

Magnesium (Mg2+)

Function: 300+ enzymatic reactions, muscle/nerve function, bone health.

Normal range: 1.7-2.2 mg/dL (0.7-1.0 mmol/L)

CKD effects: Usually normal until advanced disease; may be elevated in Stage 5.

Anemia Panel (Kidney Disease Causes Anemia)

Complete Blood Count (CBC) – Hemoglobin, Hematocrit, RBC

Kidney disease anemia:

• Mechanism: Kidneys produce erythropoietin (EPO), the hormone stimulating red blood cell production; CKD decreases EPO → anemia
• Onset: Usually Stage 3-4 CKD
• Definition: Hemoglobin <13 g/dL men, <12 g/dL women

Symptoms of anemia:

• Fatigue, weakness
• Shortness of breath
• Dizziness
• Pale skin
• Cold intolerance
• Cognitive impairment

Treatment:

• Erythropoiesis-Stimulating Agents (ESA): Epoetin alfa, darbepoetin (injections mimicking natural EPO)
• Iron supplementation: Oral or IV iron (EPO requires adequate iron)
• Target hemoglobin: 10-11.5 g/dL (not higher—increased cardiovascular risk)

Iron Studies (Ferritin, Transferrin Saturation)

Why important: Iron deficiency is common in CKD (blood loss, poor absorption, inflammation); required for EPO effectiveness.

Targets for CKD patients:

• Ferritin: >100 ng/mL (higher than general population)
• Transferrin saturation: >20%

Treatment: Oral iron often ineffective; IV iron frequently needed.

Urine Tests (Essential for Kidney Disease Detection)

Urinalysis – Comprehensive Urine Examination

Components analyzed:

Color and Clarity:

• Normal: Pale to dark yellow, clear
• Abnormal: Red/brown (blood), cloudy (infection, crystals), foamy (protein)

Specific Gravity:

• Measures urine concentration
• Normal: 1.005-1.030
• High: Dehydration
• Low: Overhydration, diabetes insipidus, kidney concentration defect

pH:

• Normal: 4.5-8.0
• Helps evaluate kidney stones, infections, acid-base disorders

Protein (Qualitative):

• Normal: Negative or trace
• Positive (1+, 2+, 3+, 4+): Kidney damage (glomerular or tubular disease)
• Persistent proteinuria: Hallmark of chronic kidney disease

Glucose:

• Normal: Negative
• Positive: Diabetes (blood sugar >180 mg/dL), rare kidney tubular disorders

Ketones:

• Normal: Negative
• Positive: Diabetic ketoacidosis, starvation, very low-carb diet

Blood (Hematuria):

• Normal: Negative
• Positive: Infection, stones, trauma, glomerulonephritis, cancer, vigorous exercise
• Microscopic hematuria requires investigation (cystoscopy, imaging)

Leukocyte Esterase and Nitrites:

• Positive: Urinary tract infection (UTI)

Microscopic Examination:

• Red blood cells (RBCs): Bleeding source localization
• White blood cells (WBCs): Infection, inflammation
• Casts: Cylindrical structures formed in kidney tubules
• RBC casts: Glomerulonephritis (kidney inflammation)
• WBC casts: Pyelonephritis (kidney infection), interstitial nephritis
• Granular casts: Acute tubular necrosis, chronic kidney disease
• Hyaline casts: Normal in small amounts; increased with proteinuria
• Crystals: Calcium oxalate, uric acid, struvite (infection), cystine (genetic)
• Bacteria: Infection (if accompanied by WBCs and symptoms)
• Epithelial cells: Normal shedding; increased with contamination

Urine Albumin-to-Creatinine Ratio (UACR) – Most Sensitive Kidney Damage Marker

What it measures: Protein (specifically albumin) leakage in urine; the earliest sign of diabetic and hypertensive kidney disease.

Why critical: Detects kidney damage years before eGFR declines.

Collection: Single spot urine sample (preferably first morning void).

Normal: <30 mg/g (<3 mg/mmol)

Interpretation:

• Normal albuminuria: <30 mg/g – No kidney damage
• Microalbuminuria (now called "moderately increased albuminuria"): 30-300 mg/g (3-30 mg/mmol) – Early kidney damage, reversible with treatment
• Macroalbuminuria (severely increased albuminuria): >300 mg/g (>30 mg/mmol) – Significant kidney damage, indicates CKD

Clinical significance:

• Gold standard for diabetic and hypertensive kidney disease screening
• Independent cardiovascular risk factor (predicts heart attack/stroke)
• Treatment target: ACE inhibitors or ARBs reduce proteinuria and slow CKD progression
• Monitoring: Every 6-12 months in diabetes/hypertension; every 3-6 months if elevated

24-Hour Urine Collection (When Indicated)

Quantifies:

• Total protein excretion: Normal <150 mg/24 hours
• Creatinine clearance: Estimates GFR (less commonly used now; eGFR from blood more convenient)
• Sodium, potassium excretion: Assesses dietary intake and kidney handling

Used for: Accurate proteinuria quantification, salt intake assessment.

Additional Specialized Kidney Tests

Parathyroid Hormone (PTH) – Bone Health Marker

Function: Regulates calcium and phosphorus; maintains bone health.

Normal range: 10-65 pg/mL

Kidney disease complication:

• Secondary hyperparathyroidism: Low calcium + high phosphorus + low vitamin D (from CKD) → stimulates excessive PTH production
• Onset: Stage 3-4 CKD
• Consequences: renal osteodystrophy (bone disease causing pain, fractures, deformities), vascular calcification, itching

Targets for CKD:

• Stage 3: PTH 35-70 pg/mL
• Stage 4: PTH 70-110 pg/mL
• Stage 5: PTH 150-300 pg/mL

Treatment:

• Phosphate binders (lower phosphorus)
• Activated vitamin D (calcitriol)
• Calcimimetics (cinacalcet—lowers PTH directly)
• Low phosphorus diet

Vitamin D (25-Hydroxyvitamin D)

Kidney function: Kidneys activate vitamin D to calcitriol (active form).

CKD effect: Decreased activation → vitamin D deficiency → low calcium, high PTH, bone disease.

Normal: 30-50 ng/mL

Treatment: Ergocalciferol (vitamin D2) or cholecalciferol (D3) supplementation; calcitriol (activated form) in advanced CKD.

Cystatin C (Alternative GFR Marker)

What it measures: Protein produced by all cells; filtered by kidneys.

Advantages over creatinine:

• Not affected by muscle mass, age, race
• More sensitive for detecting early kidney dysfunction
• Better cardiovascular risk prediction

Used when: Creatinine is unreliable (extremes of muscle mass, amputation, malnutrition, elderly).

eGFR-cystatin C: Calculated from cystatin C level.

Kidney Ultrasound (Imaging—Recommended with Abnormal Results)

Not a blood/urine test, but an essential evaluation.

Detects:

• Kidney size (small kidneys indicate chronic disease; enlarged suggest acute process or obstruction)
• Polycystic kidney disease (fluid-filled cysts)
• Hydronephrosis (swelling from obstruction—stones, tumor, stricture)
• Kidney stones
• Structural abnormalities
• Masses or tumors

Ordered when: Abnormal kidney function, hematuria, family history of PKD, suspected obstruction.

Understanding Your Kidney Test Results: What They Mean

Normal Results

• eGFR: >90 mL/min
• Creatinine: Normal range
• UACR: <30 mg/g
• No proteinuria, hematuria, or cellular casts
• Electrolytes balanced

Interpretation: Healthy kidney function; continue preventive measures.

Action: Rescreen based on risk factors (annually if diabetes/hypertension; every 2-3 years if low risk).

Stage 1-2 CKD (eGFR >60, Proteinuria Present)

Findings:

• eGFR ≥60 mL/min (normal function)
• BUT persistent proteinuria (UACR ≥30 mg/g) or imaging abnormality

Interpretation: Early kidney damage with preserved function; highly treatable.

Action:

• Treat underlying cause: Optimize diabetes control (HbA1c <7%), blood pressure control (<130/80)
• Kidney-protective medications: ACE inhibitors (lisinopril, enalapril) or ARBs (losartan, valsartan)—reduce proteinuria and slow progression
• Lifestyle: Weight loss if obese, low-salt diet (<2g sodium/day), regular exercise, smoking cessation
• Monitor: Repeat eGFR and UACR every 6-12 months
• Prognosis: Progression can be prevented or significantly slowed

Stage 3a CKD (eGFR 45-59)

Findings:

• Mild-moderate kidney function reduction
• May or may not have proteinuria

Interpretation: Chronic kidney disease; requires treatment to prevent progression.

Action:

• Nephrology referral (kidney specialist consultation)
• Medications: ACE inhibitors or ARBs (kidney protection, BP control), SGLT2 inhibitors if diabetic (empagliflozin, dapagliflozin—proven kidney protection), statin for cardiovascular protection
• Monitor complications: Check for anemia (CBC), bone disease (calcium, phosphorus, PTH, vitamin D)
• Medication review: Avoid NSAIDs; adjust doses of other medications based on kidney function
• Monitoring: Every 3-6 months (eGFR, UACR, electrolytes, CBC)
• Prognosis: Can remain stable for years with proper management

Stage 3b CKD (eGFR 30-44)

Findings:

• Moderate-severe reduction
• Often proteinuria present
• Complications developing

Interpretation: Established CKD requiring specialty care and complication management.

Action:

• Regular nephrology care (every 3 months minimum)
• Treat complications: anemia (EPO injections if hemoglobin <10 g/dL, IV iron), bone disease (vitamin D supplementation, phosphate binders if phosphorus elevated), metabolic acidosis (sodium bicarbonate if bicarbonate <22), hyperkalemia (low-potassium diet, potassium binders if needed)
• Cardiovascular protection: Aggressive BP and cholesterol control
• Dietitian referral: Low-protein diet (0.6-0.8 g/kg/day), low potassium, low phosphorus
• Monitoring: Every 2-3 months
• Prognosis: Risk of progression; focus on slowing decline

Stage 4 CKD (eGFR 15-29)

Findings:

• Severe kidney impairment
• Multiple complications present
• Symptoms often developing

Interpretation: Pre-dialysis; preparation for renal replacement therapy.

Action:

• Nephrology specialty center with dialysis/transplant capabilities
• Dialysis preparation: vascular access placement (AV fistula creation requires 3-6 months to mature before use), dialysis education on modality options (hemodialysis vs. peritoneal dialysis)
• Transplant evaluation: If suitable candidate, begin workup
• Intensive complication management: As Stage 3b plus more aggressive
• Dietary: Renal diet with strict potassium, phosphorus, sodium, protein restriction
• Monitoring: Monthly visits; frequent labs
• Prognosis: Likely progression to Stage 5 within 1-3 years; prepare for dialysis or transplant

Stage 5 CKD / ESRD (eGFR <15)

Findings:

• Kidney failure
• Severe uremia symptoms
• Life-threatening complications

Interpretation: Requires renal replacement therapy for survival.

Action required:

• DIALYSIS: hemodialysis (3-4 hours, 3x weekly at a dialysis center or home) or peritoneal dialysis (daily exchanges at home, continuous or cycler)
• OR KIDNEY TRANSPLANTATION: living donor (best outcomes) or deceased donor (waitlist 3-5 years average in UAE)
• Without treatment: Fatal within weeks to months
• Prognosis: Dialysis—5-year survival 35-50% (varies by age, comorbidities); transplant—10-year graft survival 60-80% with significantly better quality of life than dialysis

The Home Testing Experience: Comprehensive Kidney Assessment

Step 1: Simple Scheduling

• Book online, phone, or WhatsApp
• Fasting recommended (8-12 hours) for accurate glucose, lipid assessment
• First morning urine sample provides most accurate protein measurement
• Instructions provided for proper urine collection

Step 2: Professional Home Collection (20 Minutes)

A DHA-licensed phlebotomist and specimen collector arrives with:

• Sterile blood collection equipment
• Urine specimen collection container
• Professional credentials

Services provided:

• Health history review (diabetes, hypertension, medications, symptoms)
• Blood draw: 2-3 vials (painless, expert technique)
• Urine sample collection: Spot urine for UACR (or 24-hour collection container if ordered)
• Proper sample handling, labeling, storage
• Immediate secure transport

Preparation:

• Blood test: Fast 8-12 hours (water permitted)
• Urine test: First morning void preferred (most concentrated)
• Continue all medications unless instructed otherwise

Step 3: Accredited Nephrology Laboratory Processing

• CAP/CLIA accredited laboratories
• Automated chemistry analyzers
• Specialized urine analysis equipment
• Quality control protocols
• Secure data management

Results timeline:

• Standard kidney panel: 24 hours
• Complete with urine microscopy: 24-48 hours
• Specialized tests (cystatin C, PTH): 2-3 days

Step 4: Comprehensive Results Report

You receive:

• All kidney function test values
• eGFR calculation with CKD staging
• UACR result with interpretation
• Electrolyte panel with reference ranges
• Anemia markers
• Urinalysis complete results
• Abnormal values clearly flagged
• CKD stage determination (if applicable)
• Trend analysis if repeat testing
• Secure digital delivery

Step 5: Nephrologist or Physician Consultation & Kidney Protection Plan

Included medical consultation:

• Board-certified nephrologist or physician reviews complete results
• Calculates and explains eGFR and CKD stage
• Assesses proteinuria significance
• Evaluates electrolyte and metabolic status
• Creates personalized kidney protection/treatment plan

Treatment Approaches Based on Findings

Early CKD (Stage 1-2)

• Diabetes control: HbA1c <7% (prevent diabetic nephropathy)
• Blood pressure control: <130/80 mmHg (ACE inhibitors or ARBs first-line)
• Lifestyle modifications: weight loss if obese (7-10% reduction), low-sodium diet (<2g/day), regular exercise (150 min/week moderate), smoking cessation (critical), limit alcohol
• Medications: ACE inhibitors or ARBs (kidney protection, reduce proteinuria), SGLT2 inhibitors if diabetic (empagliflozin, dapagliflozin—proven kidney and heart protection), statin (cardiovascular protection—CKD increases heart disease risk)
• Avoid: NSAIDs (ibuprofen, naproxen), contrast dye when possible
• Monitoring: eGFR and UACR every 6-12 months

Moderate CKD (Stage 3)

• All above measures, plus:
• Nephrology referral for specialty care
• Complication screening and treatment: anemia (check CBC; EPO if hemoglobin <10 g/dL), bone disease (check calcium, phosphorus, PTH, vitamin D; supplement as needed), metabolic acidosis (bicarbonate supplementation if low)
• Medication adjustments: Many drugs require dose reduction based on eGFR
• Dietary modification: Consider low-protein diet (0.8 g/kg/day) under dietitian guidance
• Monitoring: Every 3-6 months

Advanced CKD (Stage 4-5)

• All above, plus:
• Dialysis/transplant preparation: vascular access placement (fistula), dialysis modality education, transplant evaluation if suitable candidate
• Intensive complication management: renal diet (restricted protein, potassium, phosphorus, sodium), phosphate binders (sevelamer, calcium carbonate), EPO for anemia, vitamin D (calcitriol), bicarbonate for acidosis, potassium binders if hyperkalemia
• Monitoring: Monthly visits, frequent labs

Kidney Transplant Candidates

• Workup includes: Blood typing, HLA typing, antibody screening, infectious disease testing, cardiac evaluation, cancer screening
• Living donor evaluation (family, friends)
• Waitlist registration if suitable

Success Stories: Kidneys Saved Through Early Detection

"Diabetic for 12 years, never had kidney testing. Kidney Package showed eGFR 52 (Stage 3a CKD), UACR 180 mg/g (significant proteinuria). Started ACE inhibitor and SGLT2 inhibitor, improved diabetes control (HbA1c from 8.2% to 6.4%). One year later: eGFR 58, UACR 45 mg/g—improving! Nephrologist said catching it at Stage 3 prevented inevitable progression to dialysis." – Mohammed A., 58, Sales Manager, Dubai

"High BP for 10 years, uncontrolled. Screening revealed eGFR 38 (Stage 3b), proteinuria. Shocked—had NO symptoms. Aggressive BP control with medications, diet changes. Two years of monitoring: eGFR stable at 40, proteinuria decreased 50%. Avoiding dialysis by taking kidney disease seriously early." – Ahmed K., 62, Retired, Sharjah

"Family history of polycystic kidney disease (PKD)—father on dialysis. Age 35, no symptoms, did screening. Kidney ultrasound showed multiple cysts, eGFR 75 (early PKD). Started BP control, close monitoring. Five years later: eGFR 72, stable. Genetic counseling, family planning with IVF to prevent passing it to children. Early detection gave me options." – Sarah L., 40, Marketing Professional, Dubai Marina

"Chronic NSAID use for back pain (ibuprofen daily for 2 years). Fatigue, swelling in legs. Kidney tests: eGFR 42, proteinuria. Stopped NSAIDs immediately, started physical therapy instead. Six months later: eGFR 55—recovering! Medications were destroying my kidneys and I had no idea." – James R., 48, Construction Manager, Ajman

Kidney Health Package Pricing

Comprehensive Renal Function Panel

Includes:

• Serum Creatinine with eGFR calculation
• Blood Urea Nitrogen (BUN)
• Uric Acid
• Complete Electrolyte Panel (Sodium, Potassium, Chloride, Bicarbonate, Calcium, Phosphorus, Magnesium)
• Complete Blood Count (CBC—anemia screening)
• Fasting Glucose and HbA1c
• Lipid Profile
• Comprehensive Urinalysis with Microscopy
• Urine Albumin-to-Creatinine Ratio (UACR)—critical early damage marker
• Home blood and urine collection by DHA professional
• Accredited nephrology laboratory processing
• CKD staging determination
• Nephrologist or physician consultation
• Personalized kidney protection plan
• Detailed results report
• Follow-up support

Enhanced Kidney Panel (All of the Above, Plus)

• Parathyroid Hormone (PTH—bone disease marker)
• Vitamin D (25-Hydroxyvitamin D)
• Cystatin C (alternative GFR marker)
• Iron Studies (Ferritin, Transferrin Saturation—anemia evaluation)
• 24-Hour Urine Collection (protein quantification, creatinine clearance)

CKD Monitoring Program (Quarterly)

• Every 3 months kidney function monitoring
• Track disease progression or treatment response
• Early complication detection (anemia, bone disease, electrolyte imbalances)
• Medication optimization
• Ongoing nephrology support

Kidney Ultrasound (If Abnormal Results)

• Arranged at an accredited imaging center or via mobile ultrasound
• Detects structural abnormalities, kidney size, obstruction, cysts

Insurance: Most UAE health insurance plans cover kidney function testing—we provide comprehensive documentation for reimbursement.

Call or WhatsApp Dr. Sunny on +971 6 559 4900 for current package pricing.

Service Coverage: All UAE Emirates

Complete home kidney testing is available across Dubai, Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah, Fujairah, and Abu Dhabi (advance booking).

Book Your Kidney Health Package Today

Your kidneys filter your blood 60+ times daily. Protect them. Early detection prevents dialysis.

Call or WhatsApp: +971 6 559 4900 — available 7 days a week with early morning collection across Dubai, Sharjah, Ajman, and all UAE emirates.

Why Choose Our Kidney Health Package

• Complete assessment – eGFR, UACR, electrolytes, anemia
• CKD staging – Know your kidney function level
• Early damage detection – UACR catches disease before eGFR declines
• Nephrologist consultation – Expert kidney specialist interpretation
• Diabetes & hypertension screening – Identify kidney disease causes
• 100% home service – Blood and urine collection at home
• Accredited nephrology labs – Accurate, reliable results
• Insurance accepted – Affordable kidney protection
• Monitoring programs – Track kidney health over time

Protect your kidneys before damage is irreversible. Book your comprehensive kidney screening now.